Also Known As: Amoxicillin/clavulanic acid, Augmentin
Amoxicillin/clavulanic acid (INN) or co-amoxiclav (BAN) is a combination antibiotic consisting of amoxicillin trihydrate, a Î²-lactam antibiotic, and potassium clavulanate, a Î²-lactamase inhibitor. This combination results in an antibiotic with an increased spectrum of action and restored efficacy against amoxicillin-resistant bacteria that produce Î²-lactamase.
Unlike co-trimoxazole, the BAN has not been widely adopted internationally. Trade names include Augmentin (by GlaxoSmithKline),Clavamox (by Pfizer), and CLAMP (by Dr. Reddy's Laboratories).